| 2026 |
| 04/22 | 4,615 | 4,640 | 4,540 | 4,570 | -1.72% | 59,200 | 2126億9687万 | -3.08% |
| 04/21 | 4,730 | 4,735 | 4,640 | 4,650 | -2.11% | 50,700 | 2164億2023万 | -1.34% |
| 04/20 | 4,840 | 4,840 | 4,750 | 4,750 | -1.86% | 50,500 | 2210億7442万 | +0.91% |
| 04/17 | 4,785 | 4,850 | 4,785 | 4,840 | +1.15% | 58,500 | 2252億6320万 | +3.07% |
| 04/16 | 4,785 | 4,820 | 4,785 | 4,785 | -0.62% | 29,000 | 2227億339万 | +2.18% |
| 04/15 | 4,770 | 4,820 | 4,760 | 4,815 | +1.69% | 61,100 | 2240億9965万 | +2.95% |
| 04/14 | 4,700 | 4,760 | 4,690 | 4,735 | +0.74% | 60,700 | 2203億7629万 | +1.44% |
| 04/13 | 4,700 | 4,745 | 4,685 | 4,700 | 0% | 77,400 | 2187億4732万 | +0.82% |
| 04/10 | 4,745 | 4,790 | 4,670 | 4,700 | -1.47% | 69,700 | 2187億4732万 | +0.88% |
| 04/09 | 4,780 | 4,850 | 4,770 | 4,770 | -0.63% | 72,400 | 2220億526万 | +2.45% |
| 04/08 | 4,905 | 4,905 | 4,795 | 4,800 | -0.72% | 61,300 | 2234億152万 | +3.23% |
| 04/07 | 4,825 | 4,870 | 4,795 | 4,835 | +0.1% | 47,000 | 2250億3049万 | +4% |
| 04/06 | 4,895 | 4,925 | 4,825 | 4,830 | +0.1% | 65,400 | 2247億9778万 | +3.87% |
| 04/03 | 4,870 | 4,920 | 4,780 | 4,825 | -0.82% | 37,700 | 2245億6507万 | +3.61% |
| 04/02 | 4,905 | 4,940 | 4,860 | 4,865 | +1.14% | 117,300 | 2264億2675万 | +4.49% |
| 04/01 | 4,720 | 4,810 | 4,700 | 4,810 | +3.44% | 65,300 | 2238億6694万 | +3.29% |
| 03/31 | 4,640 | 4,685 | 4,615 | 4,650 | -0.43% | 77,800 | 2164億2023万 | -0.21% |
| 03/30 | 4,550 | 4,675 | 4,535 | 4,670 | -1.99% | 88,100 | 2173億5106万 | +0.13% |
| 03/27 | 4,705 | 4,765 | 4,695 | 4,765 | +1.38% | 95,500 | 2217億7255万 | +2.14% |
| 03/26 | 4,700 | 4,710 | 4,650 | 4,700 | +1.08% | 72,900 | 2187億4732万 | +0.84% |
| 03/25 | 4,670 | 4,705 | 4,635 | 4,650 | +1.09% | 95,300 | 2164億2023万 | -0.13% |
| 03/24 | 4,490 | 4,600 | 4,455 | 4,600 | +4.07% | 104,300 | 2140億9313万 | -1.16% |
| 03/23 | 4,475 | 4,480 | 4,390 | 4,420 | -2.54% | 69,600 | 2057億1557万 | -5.07% |
| 03/19 | （IR情報）10:00 子宮筋腫治療薬イセルティ錠100mg新発売のお知らせ |
| 03/19 | 4,565 | 4,595 | 4,505 | 4,535 | -1.41% | 183,800 | 2110億6790万 | -2.79% |
| 03/18 | 4,545 | 4,600 | 4,545 | 4,600 | +1.43% | 75,300 | 2140億9313万 | -1.5% |
| 03/17 | 4,505 | 4,550 | 4,500 | 4,535 | +1.23% | 42,800 | 2110億6790万 | -2.85% |
| 03/16 | 4,500 | 4,515 | 4,465 | 4,480 | -0.33% | 64,500 | 2085億809万 | -4.03% |
| 03/13 | 4,490 | 4,560 | 4,485 | 4,495 | -0.44% | 100,900 | 2092億622万 | -3.83% |
| 03/13 | （空売り報告）モルガン・スタンレーMUFG証券 227,986株（0.48%）-0.11%義務消失 |
| 03/12 | 4,620 | 4,630 | 4,505 | 4,515 | -2.27% | 70,300 | 2101億3706万 | -3.53% |
| 03/11 | 4,670 | 4,690 | 4,620 | 4,620 | +0.33% | 61,400 | 2150億2397万 | -1.41% |
| 03/10 | 4,650 | 4,660 | 4,580 | 4,605 | +0.55% | 80,200 | 2143億2584万 | -1.75% |
| 03/09 | 4,500 | 4,610 | 4,485 | 4,580 | -0.65% | 97,800 | 2131億6229万 | -2.26% |
| 03/06 | 4,590 | 4,650 | 4,555 | 4,610 | -0.75% | 126,300 | 2145億5855万 | -1.62% |
| 03/05 | 4,670 | 4,730 | 4,640 | 4,645 | +0.98% | 114,600 | 2161億8752万 | -0.79% |
| 03/04 | 4,650 | 4,720 | 4,575 | 4,600 | -3.97% | 108,200 | 2140億9313万 | -1.77% |
| 03/03 | 4,790 | 4,860 | 4,750 | 4,790 | -1.44% | 103,700 | 2229億3610万 | +2.18% |
| 03/03 | （空売り報告）モルガン・スタンレーMUFG証券 278,186株（0.59%）-0.02% |
| 03/02 | 4,935 | 4,955 | 4,850 | 4,860 | -2.99% | 76,200 | 2261億9404万 | +3.69% |
| 02/27 | （IR情報）15:30 従業員持株会に対する譲渡制限付株式としての自己株式処分に関するお知らせ |
| 02/27 | 4,840 | 5,040 | 4,830 | 5,010 | +4.59% | 213,600 | 2331億7534万 | +7.03% |
| 02/26 | 4,900 | 4,915 | 4,740 | 4,790 | -2.24% | 114,700 | 2229億3610万 | +2.64% |
| 02/25 | 4,840 | 4,900 | 4,805 | 4,900 | +0.72% | 101,000 | 2280億5572万 | +5.08% |
| 02/24 | 4,775 | 4,875 | 4,745 | 4,865 | +2.42% | 134,000 | 2264億2675万 | +4.53% |
| 02/24 | （空売り報告）モルガン・スタンレーMUFG証券 288,196株（0.61%）+0.09% |
| 02/20 | 4,690 | 4,790 | 4,670 | 4,750 | +0.96% | 134,600 | 2210億7442万 | +2.19% |
| 02/19 | 4,645 | 4,705 | 4,625 | 4,705 | +1.07% | 110,000 | 2189億8003万 | +1.25% |
| 02/19 | （空売り報告）モルガン・スタンレーMUFG証券 244,296株（0.52%）新規 |
| 02/18 | 4,640 | 4,695 | 4,630 | 4,655 | +1.42% | 74,900 | 2166億5294万 | +0.15% |
| 02/17 | 4,595 | 4,630 | 4,585 | 4,590 | -0.33% | 47,700 | 2136億2771万 | -1.35% |
| 02/16 | 4,660 | 4,660 | 4,565 | 4,605 | -0.97% | 63,800 | 2143億2584万 | -1.18% |
| 02/13 | 4,600 | 4,650 | 4,570 | 4,650 | +0.43% | 60,500 | 2164億2023万 | -0.34% |
| 02/12 | 4,660 | 4,675 | 4,615 | 4,630 | -0.64% | 72,800 | 2154億8939万 | -0.77% |
| 02/10 | 4,590 | 4,720 | 4,565 | 4,660 | +2.08% | 131,400 | 2168億8565万 | -0.11% |
| 02/09 | 4,600 | 4,600 | 4,545 | 4,565 | +0.77% | 66,600 | 2124億6416万 | -2.12% |
| 02/06 | 4,600 | 4,605 | 4,520 | 4,530 | -1.95% | 93,600 | 2108億3519万 | -2.94% |
| 02/05 | 4,690 | 4,705 | 4,620 | 4,620 | -0.65% | 114,800 | 2150億2397万 | -1.07% |
| 02/04 | 4,675 | 4,745 | 4,650 | 4,650 | -0.53% | 103,500 | 2164億2023万 | -0.41% |
| 02/03 | 4,625 | 4,725 | 4,605 | 4,675 | +1.08% | 88,800 | 2175億8377万 | +0.13% |
| 02/02 | 4,660 | 4,690 | 4,530 | 4,625 | +0.54% | 104,800 | 2152億5668万 | -0.92% |
| 01/30 | （IR情報）15:30 2026年3月期第3四半期決算短信〔日本基準〕(連結) |
| 01/30 | （IR情報）15:30 配当予想の修正(創立80周年記念配当実施)に関するお知らせ |
| 01/30 | （IR情報）15:30 2026年3月期第3四半期決算補足資料 |
| 01/30 | 4,595 | 4,645 | 4,540 | 4,600 | +0.88% | 80,200 | 2140億9313万 | -1.46% |
| 01/29 | 4,560 | 4,560 | 4,500 | 4,560 | +0.66% | 94,700 | 2122億3145万 | -2.29% |
| 01/28 | 4,600 | 4,605 | 4,510 | 4,530 | -2.79% | 65,400 | 2108億3519万 | -2.98% |
| 01/27 | 4,650 | 4,675 | 4,625 | 4,660 | -1.17% | 84,700 | 2168億8565万 | -0.3% |
| 01/26 | 4,705 | 4,730 | 4,660 | 4,715 | -1.26% | 62,400 | 2194億4545万 | +0.9% |
| 01/23 | 4,745 | 4,795 | 4,735 | 4,775 | +1.27% | 51,800 | 2222億3797万 | +2.27% |
| 01/22 | 4,650 | 4,725 | 4,650 | 4,715 | +1.4% | 44,600 | 2194億4545万 | +1.14% |
| 01/21 | 4,665 | 4,675 | 4,635 | 4,650 | -0.85% | 41,400 | 2164億2023万 | -0.13% |
| 01/20 | 4,675 | 4,695 | 4,645 | 4,690 | +0.21% | 43,300 | 2182億8190万 | +0.77% |
| 01/19 | 4,730 | 4,730 | 4,675 | 4,680 | -0.95% | 37,200 | 2178億1648万 | +0.62% |
| 01/16 | 4,690 | 4,725 | 4,650 | 4,725 | 0% | 36,400 | 2199億1087万 | +1.68% |
| 01/15 | 4,725 | 4,775 | 4,710 | 4,725 | 0% | 45,000 | 2199億1087万 | +1.81% |
| 01/14 | 4,765 | 4,790 | 4,705 | 4,725 | -0.84% | 46,500 | 2199億1087万 | +2.01% |
| 01/13 | 4,780 | 4,815 | 4,755 | 4,765 | -0.31% | 46,400 | 2217億7255万 | +3% |
| 01/09 | 4,800 | 4,805 | 4,740 | 4,780 | +0.53% | 78,900 | 2224億7068万 | +3.53% |
| 01/08 | 4,700 | 4,780 | 4,685 | 4,755 | +2.26% | 102,100 | 2213億713万 | +3.12% |
| 01/07 | 4,570 | 4,705 | 4,570 | 4,650 | +0.87% | 97,300 | 2164億2023万 | +0.93% |
| 01/06 | 4,610 | 4,640 | 4,595 | 4,610 | -0.11% | 47,800 | 2145億5855万 | +0.04% |
| 01/05 | 4,620 | 4,645 | 4,585 | 4,615 | -0.75% | 45,500 | 2147億9126万 | +0.11% |
| 2025 |
| 12/30 | 4,670 | 4,670 | 4,590 | 4,650 | +1.09% | 53,700 | 2164億2023万 | +0.87% |
| 12/29 | 4,610 | 4,610 | 4,565 | 4,600 | -0.22% | 46,900 | 2140億9313万 | -0.15% |
| 12/26 | 4,610 | 4,630 | 4,580 | 4,610 | -0.75% | 41,000 | 2145億5855万 | +0.11% |
| 12/25 | 4,675 | 4,675 | 4,610 | 4,645 | +0.22% | 46,700 | 2161億8752万 | +1.11% |
| 12/24 | 4,635 | 4,655 | 4,605 | 4,635 | 0% | 46,000 | 2157億2210万 | +1.22% |
| 12/23 | 4,580 | 4,635 | 4,570 | 4,635 | +1.53% | 39,400 | 2157億2210万 | +1.6% |
| 12/22 | （IR情報）15:30 GnRHアンタゴニスト「イセルティ錠100mg」の子宮筋腫を適応症とした国内製造販売承認取得のお知らせ |
| 12/22 | 4,605 | 4,605 | 4,515 | 4,565 | -0.98% | 45,900 | 2124億6416万 | +0.46% |
| 12/19 | 4,630 | 4,650 | 4,610 | 4,610 | -0.97% | 41,600 | 2145億5855万 | +1.83% |
| 12/18 | 4,650 | 4,675 | 4,635 | 4,655 | +0.32% | 51,500 | 2166億5294万 | +3.26% |
| 12/17 | 4,640 | 4,650 | 4,575 | 4,640 | +0.54% | 49,500 | 2159億5481万 | +3.41% |
| 12/16 | 4,590 | 4,635 | 4,570 | 4,615 | +0.44% | 65,900 | 2147億9126万 | +3.36% |
| 12/15 | 4,605 | 4,635 | 4,520 | 4,595 | +0.33% | 83,000 | 2138億6042万 | +3.4% |
| 12/12 | 4,650 | 4,670 | 4,565 | 4,580 | -0.11% | 56,800 | 2131億6229万 | +3.6% |
| 12/11 | 4,660 | 4,660 | 4,550 | 4,585 | -0.97% | 46,300 | 2133億9500万 | +4.25% |
| 12/10 | 4,580 | 4,660 | 4,570 | 4,630 | +0.98% | 38,200 | 2154億8939万 | +5.83% |
| 12/09 | 4,585 | 4,610 | 4,535 | 4,585 | +0.22% | 47,700 | 2133億9500万 | +5.4% |
| 12/08 | 4,535 | 4,605 | 4,530 | 4,575 | +1.89% | 45,200 | 2129億2958万 | +5.71% |
| 12/05 | 4,510 | 4,530 | 4,415 | 4,490 | -1.64% | 67,700 | 2089億7351万 | +4.32% |
| 12/04 | 4,550 | 4,585 | 4,530 | 4,565 | +0.33% | 48,700 | 2124億6416万 | +6.56% |
| 12/03 | 4,575 | 4,605 | 4,550 | 4,550 | -1.73% | 74,000 | 2117億6603万 | +6.68% |
| 12/02 | 4,630 | 4,660 | 4,540 | 4,630 | -0.32% | 65,000 | 2154億8939万 | +8.92% |
| 12/01 | （IR情報）15:30 配当支払開始予定日の変更に関するお知らせ |
| 12/01 | 4,685 | 4,725 | 4,630 | 4,645 | -1.06% | 81,200 | 2161億8752万 | +9.78% |
| 11/28 | 4,660 | 4,780 | 4,635 | 4,695 | +0.86% | 89,300 | 2185億1461万 | +11.44% |
| 11/27 | 4,610 | 4,655 | 4,600 | 4,655 | +1.2% | 67,100 | 2166億5294万 | +11.07% |
| 11/26 | 4,580 | 4,610 | 4,560 | 4,600 | +0.44% | 105,900 | 2140億9313万 | +10.29% |
| 11/25 | 4,510 | 4,585 | 4,490 | 4,580 | +0.66% | 112,000 | 2131億6229万 | +10.26% |
10年以上蓄積したファイナンスデータとAIを掛け合わせて、投資の意思決定を加速させるポジションです。
